Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
3h agoVeradermics to Hold Conference Call to Discuss Topline Results from Phase 2/3 ‘302’ Study of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Loss
3h agoNOBLE CORPORATION PLC ANNOUNCES FIRST QUARTER 2026 RESULTS
6h agoData at Heart Rhythm 2026 highlight key Boston Scientific therapies
7h agoOruka Therapeutics to Host Conference Call to Report Week 16 Data for ORKA-001 from the Ongoing EVERLAST-A Trial on April 27, 2026
8h agoSmart Money Quietly Accumulating as Lithium Demand Surges - Early Positioning in Elektros Signals Rare Ground-Floor Opportunity

Maplight Therapeutics, Inc. Common Stock

About

Maplight Therapeutics, Inc. Common Stock (NASDAQ:MPLT) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 26 2026
MapLight Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Mar 2 2026
MapLight Therapeutics to Participate in Upcoming Investor Conferences
Jan 9 2026
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
Jan 5 2026
MapLight Therapeutics Receives Fast Track Designation for ML-007C-MA for Alzheimer’s Disease Psychosis
Dec 16 2025
SandboxAQ and MapLight Therapeutics Announce Strategic Collaboration to Discover and Develop Novel CNS Therapies

Community Chat

Ask AI

6ix6ix